SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-18-000010
Filing Date
2018-08-07
Accepted
2018-08-07 15:27:47
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20180630x10q.htm 10-Q 830378
2 EXHIBIT 31.1 ex-311q22018.htm EX-31.1 10542
3 EXHIBIT 31.2 ex-312q22018.htm EX-31.2 11789
4 EXHIBIT 32.1 ex-321q22018.htm EX-32.1 6169
5 EXHIBIT 32.2 ex-322q22018.htm EX-32.2 6210
  Complete submission text file 0001113148-18-000010.txt   3517813

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT infi-20180630.xml EX-101.INS 581799
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20180630.xsd EX-101.SCH 34232
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20180630_cal.xml EX-101.CAL 55636
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20180630_def.xml EX-101.DEF 121197
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20180630_lab.xml EX-101.LAB 390564
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20180630_pre.xml EX-101.PRE 215792
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 18997716
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences